# Ketogenic Diet Treatment of Obesity With Co-morbid Type 2 Diabetes Mellitus and/or Obstructive Sleep Apnea

> **NCT02069197** · PHASE2 · UNKNOWN · sponsor: **Mid-Atlantic Epilepsy and Sleep Center, LLC** · enrollment: 150 (estimated)

## Conditions studied

- Obesity
- Diabetes
- Obstructive Sleep Apnea

## Interventions

- **OTHER:** Ketogenic diet
- **DRUG:** Orlistat
- **OTHER:** Standardized diet

## Key facts

- **NCT ID:** NCT02069197
- **Lead sponsor:** Mid-Atlantic Epilepsy and Sleep Center, LLC
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01
- **Primary completion:** 2020-08
- **Final completion:** 2020-09
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2018-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02069197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02069197, "Ketogenic Diet Treatment of Obesity With Co-morbid Type 2 Diabetes Mellitus and/or Obstructive Sleep Apnea". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02069197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*